Th17 expansion in MS patients is counterbalanced by an expanded CD39+ regulatory T cell population during remission but not during relapse.
about
Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristicsAntigen Presentation, Autoantigens, and Immune Regulation in Multiple Sclerosis and Other Autoimmune DiseasesKv1.3 channel blocker (ImKTx88) maintains blood-brain barrier in experimental autoimmune encephalomyelitis.The contribution of immune and glial cell types in experimental autoimmune encephalomyelitis and multiple sclerosisGalectin-9 and IL-21 mediate cross-regulation between Th17 and Treg cells during acute hepatitis C.Inhibition of RORγt activity and Th17 differentiation by a set of novel compounds.A commensal symbiotic factor derived from Bacteroides fragilis promotes human CD39(+)Foxp3(+) T cells and Treg functionRegulatory T cells and Th17 cells in viral infections: implications for multiple sclerosis and myocarditis.CD39 and CD73 in immunity and inflammation.GWAS analysis implicates NF-κB-mediated induction of inflammatory T cells in multiple sclerosis.Vitamin D in multiple sclerosis: implications for assessment and treatment.Role of regulatory T cells in pathogenesis and biological therapy of multiple sclerosis.Further understanding of the immunopathology of multiple sclerosis: impact on future treatments.Neural Stem Cell-Based Regenerative Approaches for the Treatment of Multiple Sclerosis.Regulation of Treg-associated CD39 in multiple sclerosis and effects of corticotherapy during relapse.Autoimmune Reactivity in Graft Injury: Player or Bystander?Increased IL-4- and IL-17-producing CD8+ cells are related to decreased CD39+CD4+Foxp3+ cells in allergic asthma.Multiparametric flow cytometric analysis of whole blood reveals changes in minor lymphocyte subpopulations of multiple sclerosis patients.Purinergic Profiling of Regulatory T-cells in Patients With Episodic MigraineRegulatory B and T lymphocytes in multiple sclerosis: friends or foes?
P2860
Q26998412-26F135AD-6C0C-4146-954E-2FC479CAE7F6Q28080791-C4DB358B-774B-469A-B5A9-2014A6EA3EC0Q33776820-BF4DE9A4-5064-49E4-8D83-B06B01186639Q34413247-F7CF7B27-31D2-4C6E-AD69-011F9424E0CDQ34789276-6D0EBFF4-7BF1-4E42-8840-E4A9257F1B23Q35645390-889F4A54-50F5-4C5C-94B0-350554F87935Q36191738-F83B51A0-88D7-45C6-BB44-EE7231396759Q36278700-A2EE5149-56E6-4A34-A682-5CA55A39FCC9Q36906658-7903D491-9E43-4A22-9585-852A42AC382EQ37116141-1568CFA6-DE98-4B93-A75B-FD06729FC388Q38049627-65CD45AE-38BD-4A35-9596-5AFF04CF51D8Q38114422-971570F8-4551-4D11-A527-F3C4EABB8B71Q38837294-590443A2-447E-449A-864A-43CAB7688A1FQ39279957-34686BA7-2496-4338-8917-4A152EE7F388Q41463764-5C171B65-6E8F-4FEC-8015-8BE719CE8C5BQ45763669-5AD75D52-9BE3-47F1-8F43-A690506EE0E2Q47814656-BCB413B0-9B39-4ADD-BBC3-8C7740EDE135Q50673650-8BA0ABAC-0F1B-44B3-9871-9437FFBCB53FQ57491949-8D563545-899B-4131-840F-C7A07BE1B616Q58555322-EDD9DA9F-E5DD-4422-833A-39A9F66257A7
P2860
Th17 expansion in MS patients is counterbalanced by an expanded CD39+ regulatory T cell population during remission but not during relapse.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Th17 expansion in MS patients ...... ission but not during relapse.
@en
Th17 expansion in MS patients ...... ission but not during relapse.
@nl
type
label
Th17 expansion in MS patients ...... ission but not during relapse.
@en
Th17 expansion in MS patients ...... ission but not during relapse.
@nl
prefLabel
Th17 expansion in MS patients ...... ission but not during relapse.
@en
Th17 expansion in MS patients ...... ission but not during relapse.
@nl
P2093
P1476
Th17 expansion in MS patients ...... ission but not during relapse.
@en
P2093
Evelyn Peelen
Jan Damoiseaux
Mariëlle Thewissen
Paul Menheere
Raymond Hupperts
Stephanie Knippenberg
P304
P356
10.1016/J.JNEUROIM.2011.09.013
P478
P577
2011-10-26T00:00:00Z